Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISK KLINIK SØNDERSØ ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   3.3% 2.7% 3.9% 8.7% 6.0% 7.5% 21.1% 21.1%   Credit score (0-100)   56 61 50 27 38 31 5 5   Credit rating   BBB BBB BBB BB BBB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,104 1,516 1,198 952 1,048 1,275 0.0 0.0   EBITDA   111 548 223 257 103 318 0.0 0.0   EBIT   80.0 517 217 257 103 318 0.0 0.0   Pre-tax profit (PTP)   72.0 499.0 188.0 251.7 97.2 307.5 0.0 0.0   Net earnings   56.0 389.0 146.7 196.3 75.6 243.0 0.0 0.0   Pre-tax profit without non-rec. items   72.0 499 188 252 97.2 308 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Tangible assets total   36.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   591 580 277 136 211 209 0.4 0.4   Interest-bearing liabilities   0.0 320 85.3 0.0 4.7 0.0 0.0 0.0   Balance sheet total (assets)   819 1,203 703 359 420 454 0.4 0.4   Net Debt   -557 -641 -264 -115 -143 -52.6 -0.4 -0.4     See the entire balance sheet 1000.0 Volume  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,104 1,516 1,198 952 1,048 1,275 0.0 0.0   Gross profit growth   -14.6% 37.3% -20.9% -20.6% 10.1% 21.7% -100.0% 0.0%   Employees   2 2 2 2 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   819 1,203 703 359 420 454 0 0   Balance sheet change%   -9.3% 46.9% -41.5% -49.0% 17.0% 8.1% -99.9% 0.0%   Added value   80.0 517.0 217.3 256.8 103.0 317.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -61 -62 -11 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   7.2% 34.1% 18.1% 27.0% 9.8% 24.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   9.3% 51.1% 22.8% 48.4% 26.5% 73.5% 0.0% 0.0%   ROI %   13.0% 69.3% 34.4% 103.1% 58.7% 150.9% 0.0% 0.0%   ROE %   9.1% 66.4% 34.2% 95.2% 43.6% 115.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Equity ratio %   72.2% 48.2% 39.4% 37.8% 50.3% 46.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -501.8% -117.0% -118.2% -44.8% -139.1% -16.5% 0.0% 0.0%   Gearing %   0.0% 55.2% 30.8% 0.0% 2.2% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 11.3% 14.5% 11.8% 257.8% 576.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Quick Ratio   3.4 1.9 1.6 1.9 2.2 2.4 0.0 0.0   Current Ratio   3.4 1.9 1.6 1.9 2.2 2.4 0.0 0.0   Cash and cash equivalent   557.0 961.0 349.0 114.9 148.0 52.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   555.0 575.0 276.7 174.2 228.0 267.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   40 259 109 128 52 159 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   56 274 111 128 52 159 0 0   EBIT / employee   40 259 109 128 52 159 0 0   Net earnings / employee   28 195 73 98 38 122 0 0